According to ClinicalTrials.gov, as of 5 th December 2022, no phase III clinical trial on the use of GSH in NAFLD is currently ongoing or recruiting
Can you enlighten if there are connections & potential remediation approaches, My experience & opinions==MDS JUST CANt THINK OUTSIDE THE BOX ergo is beyond most of them.Please offer nutraceutical intervention support if U can
[15] However, subsequent analysis revealed important context: the increased risk was predominantly observed in patients with pre-existing diabetic retinopathy and those who experienced rapid improvements in glycaemic control
PD clinical trials The neuroprotective effects of GLP-1RAs, particularly exenatide, seem to be more promising in PD
Smythies J, Galzigna L: The oxidative metabolism of catecholamines in the brain: a review
Carnitine plays many important functions in our bodies